SE0103437D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0103437D0
SE0103437D0 SE0103437A SE0103437A SE0103437D0 SE 0103437 D0 SE0103437 D0 SE 0103437D0 SE 0103437 A SE0103437 A SE 0103437A SE 0103437 A SE0103437 A SE 0103437A SE 0103437 D0 SE0103437 D0 SE 0103437D0
Authority
SE
Sweden
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
SE0103437A
Other languages
English (en)
Inventor
Ulf Bremberg
Patrizia Caldirola
Gary Johansson
Andrew Mott
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0103437A priority Critical patent/SE0103437D0/sv
Publication of SE0103437D0 publication Critical patent/SE0103437D0/sv
Priority to NZ529032A priority patent/NZ529032A/en
Priority to KR1020037016203A priority patent/KR100889718B1/ko
Priority to CA002445653A priority patent/CA2445653A1/en
Priority to KR1020097000129A priority patent/KR20090019894A/ko
Priority to KR1020087016920A priority patent/KR100888906B1/ko
Priority to BR0210291-9A priority patent/BR0210291A/pt
Priority to AU2002309435A priority patent/AU2002309435B2/en
Priority to HK04109896.2A priority patent/HK1066790B/xx
Priority to US10/167,141 priority patent/US7144883B2/en
Priority to CNA2005101381444A priority patent/CN1800185A/zh
Priority to YU98003A priority patent/YU98003A/sh
Priority to PCT/SE2002/001126 priority patent/WO2002100822A1/en
Priority to EA200400027A priority patent/EA008476B1/ru
Priority to MXPA03011083A priority patent/MXPA03011083A/es
Priority to EP02778916A priority patent/EP1412325A1/en
Priority to JP2003503591A priority patent/JP4731114B2/ja
Priority to CNB028103777A priority patent/CN100457726C/zh
Priority to IL15859002A priority patent/IL158590A0/xx
Priority to PL02367264A priority patent/PL367264A1/xx
Priority to NO20035496A priority patent/NO20035496D0/no
Priority to US11/509,914 priority patent/US20070066598A1/en
Priority to US11/509,989 priority patent/US20070066599A1/en
Priority to US11/510,324 priority patent/US7572787B2/en
Priority to JP2009209444A priority patent/JP2010013473A/ja
Priority to US12/781,355 priority patent/US20100222330A1/en

Links

SE0103437A 2001-06-11 2001-10-16 New compounds SE0103437D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0103437A SE0103437D0 (sv) 2001-10-16 2001-10-16 New compounds
PL02367264A PL367264A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
PCT/SE2002/001126 WO2002100822A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
MXPA03011083A MXPA03011083A (es) 2001-06-11 2002-06-11 Compuestos de sulfonamida sustituida, procedimiento para su preparacion, y su uso como medicamento para el tratamiento de trastornos del sistema nervioso central. obesidad y diabetes tipo ii.
CA002445653A CA2445653A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
KR1020097000129A KR20090019894A (ko) 2001-06-11 2002-06-11 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형 당뇨병 치료용 약제로서의 이들의 사용 방법
KR1020087016920A KR100888906B1 (ko) 2001-06-11 2002-06-11 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형당뇨병 치료용 약제로서의 이들의 사용 방법
BR0210291-9A BR0210291A (pt) 2001-06-11 2002-06-11 Compostos de sulfonamida substituìdos, processo para sua preparação e seu uso como medicamento para o tratamento de distúrbios do sistema nervoso central, obesidade e diabetes do tipo ii
AU2002309435A AU2002309435B2 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
HK04109896.2A HK1066790B (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
US10/167,141 US7144883B2 (en) 2001-06-11 2002-06-11 Bicyclic sulfonamide compounds
CNA2005101381444A CN1800185A (zh) 2001-06-11 2002-06-11 取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ii型糖尿病的药物的应用
YU98003A YU98003A (sh) 2001-06-11 2002-06-11 Supstituisana sulfonamidna jedinjenja, postupak za njihovu upotrebu kao leka za tretiranje poremećaja cns, gojaznosti i dijabetesa tipa ii
NZ529032A NZ529032A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
EA200400027A EA008476B1 (ru) 2001-06-11 2002-06-11 Замещенные сульфонамиды, способ их получения и их применение в качестве лечебного средства для лечения расстройств цнс, ожирения и диабета типа ii
KR1020037016203A KR100889718B1 (ko) 2001-06-11 2002-06-11 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형당뇨병 치료용 약제로서의 이들의 사용 방법
EP02778916A EP1412325A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
JP2003503591A JP4731114B2 (ja) 2001-06-11 2002-06-11 置換スルホンアミド化合物、ｃｎｓ障害、肥満およびｉｉ型糖尿病の処置のための医薬としてのそれらの使用方法
CNB028103777A CN100457726C (zh) 2001-06-11 2002-06-11 取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ⅱ型糖尿病的药物的应用
IL15859002A IL158590A0 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
NO20035496A NO20035496D0 (no) 2001-06-11 2003-12-10 Substituerte sulfonamidforbindelser, fremgangsmåte for deres anvendelse sommedikament til behandling av CNS-forstyrrelser, overvekt og typeII-diabetes
US11/509,914 US20070066598A1 (en) 2001-06-11 2006-08-25 Compounds
US11/509,989 US20070066599A1 (en) 2001-06-11 2006-08-25 New compounds
US11/510,324 US7572787B2 (en) 2001-06-11 2006-08-25 Substituted naphthalene sulfonamides
JP2009209444A JP2010013473A (ja) 2001-06-11 2009-09-10 置換スルホンアミド化合物、ｃｎｓ障害、肥満およびｉｉ型糖尿病の処置のための医薬としてのそれらの使用方法
US12/781,355 US20100222330A1 (en) 2001-06-11 2010-05-17 New Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103437A SE0103437D0 (sv) 2001-10-16 2001-10-16 New compounds

Publications (1)

Publication Number Publication Date
SE0103437D0 true SE0103437D0 (sv) 2001-10-16

Family

ID=20285660

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0103437A SE0103437D0 (sv) 2001-06-11 2001-10-16 New compounds

Country Status (1)

Country Link
SE (1) SE0103437D0 (sv)

Similar Documents

Publication Publication Date Title
IS6971A (is) Ný efnasambönd
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
ATE402148T1 (de) Substituierte pyridinylamine
DE50206892D1 (de) Substituierte imidazotriazinone
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE50213651D1 (de) Substituierte 4-aminocyclohexanole
ATA13992002A (de) Schlackengranulierungsanlage
DE60216967D1 (de) Substituierte cyclohexanderivate
AT500276B8 (de) Radschwenksystem
SE0101958D0 (sv) New compounds
SE0103437D0 (sv) New compounds
SE0104366D0 (sv) New compounds
SE0104342D0 (sv) New compounds
SE0103461D0 (sv) New compounds
SE0102386D0 (sv) New compounds
SE0102056D0 (sv) New Compounds
SE0101660D0 (sv) New compounds
SE0101659D0 (sv) New compounds
SE0100629D0 (sv) New compounds
SE0100272D0 (sv) New compounds
SE0100641D0 (sv) Novel compounds
SE0103271D0 (sv) Novel compounds
SE0104473D0 (sv) Novel Compounds
SE0104474D0 (sv) Novel Compounds
SE0200704D0 (sv) Novel compounds